Dynamic Investigation of Sensitivity and Action Mechanism of Antitumor Drug

被引:1
|
作者
Liu, Xuan [1 ,2 ]
Luan, Ying [1 ,2 ]
Guo, Airong
Deng, Huihua
Lu, Zuhong [2 ]
机构
[1] Southeast Univ, Minist Educ China, Key Lab Child Dev & Learning Sci, Nanjing 210096, Jiangsu, Peoples R China
[2] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China
来源
MATERIALS FOR ENVIRONMENTAL PROTECTION AND ENERGY APPLICATION, PTS 1 AND 2 | 2012年 / 343-344卷
关键词
Dynamic assay; antitumor drug; action mechanism; A549; cells; detachment duration; CELL; CYTOTOXICITY; DAUNORUBICIN; APOPTOSIS; INDUCTION; ADHESION;
D O I
10.4028/www.scientific.net/AMR.343.344.476
中图分类号
TE [石油、天然气工业]; TK [能源与动力工程];
学科分类号
0807 ; 0820 ;
摘要
Dynamic responses of A549 cells to epirubicin (EPI), daunorubicin (DNR), cisplatin (DDP) and carboplatin (CBP) were monitored by real-time cell electronic sensing (RT-CES) system. A new defined parameter, the detachment duration, was defined to quantitatively characterize drug-cell action mechanism. For DNR, there were two different linear dependent regions of the detachment duration. The rate constant of DNR in lower concentration region (20.4 +/- 2.0 h/mu M) is much larger than that in higher concentration region (3.2 +/- 0.1 h/mu M). Moreover, the rate constant of DNR in lower concentration region is close to that of EPI in higher concentration region (17.5 +/- 0.5 h/mu M). Similar observation occurred in the case of DDP and CBP treatment, and the rate constant is (2.8 +/- 0.4)x10 h/mu M and (4.6 +/- 1.3)x10 h/mu M respectively. Taken together, A549 cells are more sensitive to DNR than EPI and to DDP than CBP. This study provides new insight into cell-drug interaction. RT-CES system may play important role in future drug screening, mechanism exploration and clinical therapy.
引用
收藏
页码:476 / +
页数:3
相关论文
共 50 条
  • [1] Mechanism of antitumor drug action assessed by cytometry
    Traganos, F
    CYTOMETRY, 4TH EDITION: NEW DEVELOPMENTS, 2004, 75 : 257 - 305
  • [2] STUDIES ON MECHANISM OF ACTION OF AN EXPERIMENTAL ANTITUMOR DRUG
    WILSON, WR
    CHEMISTRY IN NEW ZEALAND, 1973, 37 (05): : 148 - 152
  • [3] MECHANISM OF ACTION OF ANTITUMOR DRUG ETOPOSIDE - A REVIEW
    VANMAANEN, JMS
    RETEL, J
    DEVRIES, J
    PINEDO, HM
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (19) : 1526 - 1533
  • [4] INVESTIGATION OF THE MECHANISM OF GLUCOCORTICOID ACTION ON DOPAMINE AGONIST SENSITIVITY
    CROCKER, AD
    STANLEY, JE
    CAMERON, DL
    NEUROCHEMISTRY INTERNATIONAL, 1992, 20 : S241 - S243
  • [5] MECHANISM OF ANTITUMOR ACTION OF DIMETHANESULFONYLTHIOPENTANE
    KUBOTA, Y
    UEKI, H
    ICHISHITA, H
    GANN, 1972, 63 (06): : 701 - 712
  • [6] Modeling the action of an antitumor drug: A density functional theory study of the mechanism of tirapazamine
    Ban, FQ
    Gauld, JW
    Boyd, RJ
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (30) : 7320 - 7325
  • [7] DNA and non-DNA targets in the mechanism of action of the antitumor drug trabectedin
    David-Cordonnier, MH
    Gajate, C
    Olmea, O
    Laine, W
    de la Igiesia-Vicente, J
    Perez, C
    Cuevas, C
    Otero, G
    Manzanares, I
    Bailly, C
    Mollinedo, F
    CHEMISTRY & BIOLOGY, 2005, 12 (11): : 1201 - 1210
  • [8] REACTIVITY AND MECHANISM OF ANTITUMOR ACTION OF TRIAZENEM
    NIFONTOV, VI
    BELSKAYA, NP
    CHERNOV, VA
    ERSHOVA, YA
    VALIDUDA, GI
    DARIENKO, EP
    NIKIFOROVA, SV
    PAKHOMOVA, EY
    PUSHKAREVA, ZV
    KHIMIKO-FARMATSEVTICHESKII ZHURNAL, 1984, 18 (09): : 1037 - 1041
  • [9] IMMUNOMODULATING MECHANISM OF ASTERINS ANTITUMOR ACTION
    SMIRNOV, VV
    MISHENKOVA, EL
    GRINEVICH, YA
    PETRENKO, GT
    MARTYNENKO, SV
    ANTIBIOTIKI I KHIMIOTERAPIYA, 1990, 35 (06) : 31 - 34
  • [10] MECHANISM OF ACTION OF CESALIN, AN ANTITUMOR AGENT
    ELTING, J
    CHIANG, CK
    YAMAUCHI, F
    MONTGOMERY, R
    FEDERATION PROCEEDINGS, 1976, 35 (07) : 1663 - 1663